FDA sets new date for panel review of Sarepta?s muscle drug
 

FDA sets new date for panel review of Sarepta?s muscle drug
(Reuters) - An independent panel of experts to the U.S. Food and Drug Administration (FDA) will discuss Sarepta Therapeutics Inc's muscle wasting drug on April 25, nearly three months after the original date.


http://rc.feedsportal.com/r/24739425...14/rc/1/rc.img

http://rc.feedsportal.com/r/24739425...14/rc/2/rc.img

http://rc.feedsportal.com/r/24739425...14/rc/3/rc.img

http://da.feedsportal.com/r/24739425...a/sc/14/a2.img
http://adchoice.feedsportal.com/r/24.../sc/14/ach.imghttp://pi.feedsportal.com/r/24739425.../sc/14/a2t.imghttp://pi2.feedsportal.com/r/2473942...sc/14/a2t2.imghttp://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...bw:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...bw:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/ljAAZd2-GKc